Dysregulation of PI3K and Hippo signaling pathways synergistically induces chronic pancreatitis via CTGF upregulation.


Journal

The Journal of clinical investigation
ISSN: 1558-8238
Titre abrégé: J Clin Invest
Pays: United States
ID NLM: 7802877

Informations de publication

Date de publication:
01 07 2021
Historique:
received: 18 08 2020
accepted: 11 05 2021
pubmed: 26 5 2021
medline: 14 10 2021
entrez: 25 5 2021
Statut: ppublish

Résumé

The role of PI3K and Hippo signaling in chronic pancreatitis (CP) pathogenesis is unclear. Therefore, we assessed the involvement of these pathways in CP by examining the PI3K and Hippo signaling components PTEN and SAV1, respectively. We observed significant decreases in pancreatic PTEN and SAV1 levels in 2 murine CP models: repeated cerulein injection and pancreatic ductal ligation. Additionally, pancreas-specific deletion of Pten and Sav1 (DKO) induced CP in mice. Pancreatic connective tissue growth factor (CTGF) was markedly upregulated in both CP models and DKO mice, and pancreatic CCAAT/enhancer-binding protein-α (CEBPA) expression was downregulated in the CP models. Interestingly, in pancreatic acinar cells (PACs), CEBPA knockdown reduced PTEN and SAV1 and increased CTGF levels in vitro. Furthermore, CEBPA knockdown in PACs induced acinar-to-ductal metaplasia and activation of cocultured macrophages and pancreatic stellate cells. These results were mitigated by CTGF inhibition. CP in DKO mice was also ameliorated by Ctgf gene deletion, and cerulein-induced CP was alleviated by antibody-mediated CTGF neutralization. Finally, we observed significantly decreased PTEN, SAV1, and CEBPA and increased CTGF levels in human CP tissues compared with nonpancreatitis tissues. Taken together, our results indicate that dysregulation of PI3K and Hippo signaling induces CP via CTGF upregulation.

Identifiants

pubmed: 34032634
pii: 143414
doi: 10.1172/JCI143414
pmc: PMC8245178
doi:
pii:

Substances chimiques

CCAAT-Enhancer-Binding Proteins 0
CCN2 protein, human 0
CCN2 protein, mouse 0
CEBPA protein, human 0
CEBPA protein, mouse 0
Cell Cycle Proteins 0
SAV1 protein, human 0
Sav1 protein, mouse 0
Connective Tissue Growth Factor 139568-91-5
Ceruletide 888Y08971B
Protein Serine-Threonine Kinases EC 2.7.11.1
PTEN Phosphohydrolase EC 3.1.3.67
PTEN protein, human EC 3.1.3.67
Pten protein, mouse EC 3.1.3.67

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Cancer Discov. 2011 Jul;1(2):158-69
pubmed: 21984975
Tumour Biol. 2016 Oct 17;:
pubmed: 27747589
Appl Immunohistochem Mol Morphol. 2010 Oct;18(5):442-7
pubmed: 20661135
Genes Dev. 2004 Aug 15;18(16):1926-45
pubmed: 15314020
Cell Commun Signal. 2019 May 17;17(1):45
pubmed: 31101053
J Biol Chem. 2016 Jul 29;291(31):16390-403
pubmed: 27129246
Proc Natl Acad Sci U S A. 2010 Nov 23;107(47):20311-6
pubmed: 21059933
Cancer Res. 2018 Sep 1;78(17):4902-4914
pubmed: 29967264
Oncotarget. 2017 May 18;8(38):62953-62961
pubmed: 28968962
Anticancer Res. 2019 Jul;39(7):3317-3321
pubmed: 31262852
Proc Natl Acad Sci U S A. 2018 Oct 30;115(44):E10417-E10426
pubmed: 30327349
Gastroenterology. 2020 May;158(6):1626-1641.e8
pubmed: 31930989
J Pineal Res. 2009 Oct;47(3):221-7
pubmed: 19663997
Nat Commun. 2015 May 18;6:7158
pubmed: 25981357
J Cell Physiol. 2019 Aug;234(10):18131-18145
pubmed: 30891776
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D108-10
pubmed: 16381825
Int J Cancer. 2009 Feb 15;124(4):827-33
pubmed: 19035457
Nat Cell Biol. 2012 Dec;14(12):1322-9
pubmed: 23143395
Hepatol Res. 2003 May;26(1):1-9
pubmed: 12787797
Mol Endocrinol. 2004 Aug;18(8):1975-87
pubmed: 15155787
Proc Natl Acad Sci U S A. 2010 Jan 26;107(4):1437-42
pubmed: 20080689
Dig Dis Sci. 2017 Jul;62(7):1702-1712
pubmed: 28501969
Cell. 2008 Jan 25;132(2):197-207
pubmed: 18243096
Ann Surg. 1999 Jul;230(1):63-71
pubmed: 10400038
Mod Pathol. 2007 Feb;20 Suppl 1:S113-31
pubmed: 17486047
J Clin Invest. 2011 Aug;121(8):3343-56
pubmed: 21747166
Sci Rep. 2019 May 8;9(1):7072
pubmed: 31068602
Sci Rep. 2015 Nov 16;5:16759
pubmed: 26567630
Mol Cancer Res. 2011 Oct;9(10):1395-405
pubmed: 21813505
Physiol Rev. 2014 Oct;94(4):1287-312
pubmed: 25287865
Immunology. 2014 Apr;141(4):564-76
pubmed: 24754049
N Engl J Med. 1993 May 20;328(20):1433-7
pubmed: 8479461
Mol Cancer Res. 2018 Jun;16(6):1046-1058
pubmed: 29545474
Liver Int. 2008 Sep;28(8):1065-79
pubmed: 18783549
Cytokine Growth Factor Rev. 2013 Feb;24(1):59-68
pubmed: 22884427
J Mol Cell Cardiol. 2018 Aug;121:205-211
pubmed: 30040954
J Exp Clin Cancer Res. 2018 Aug 22;37(1):198
pubmed: 30134988
Cancer Lett. 2014 Apr 10;345(2):203-9
pubmed: 23981573
Sci Rep. 2017 Feb 13;7:42114
pubmed: 28191821
PLoS Biol. 2019 Sep 12;17(9):e3000418
pubmed: 31513574
Nat Cell Biol. 2011 Aug 01;13(8):877-83
pubmed: 21808241
J Clin Oncol. 2009 Feb 1;27(4):619-28
pubmed: 19075268
Gastroenterology. 2016 Sep;151(3):526-39
pubmed: 27215660
J Cell Commun Signal. 2016 Jun;10(2):121-7
pubmed: 27098435
J Biol Chem. 1996 Oct 4;271(40):24753-60
pubmed: 8798745
Gastroenterology. 2010 Jun;138(7):2487-98, 2498.e1-7
pubmed: 20206174
Cancer Res. 2010 Sep 15;70(18):7114-24
pubmed: 20807812
Am J Pathol. 2007 Jul;171(1):263-73
pubmed: 17591971

Auteurs

Takeshi Tamura (T)

Department of Gastroenterology and Hepatology and.

Takahiro Kodama (T)

Department of Gastroenterology and Hepatology and.

Katsuhiko Sato (K)

Department of Gastroenterology and Hepatology and.

Kazuhiro Murai (K)

Department of Gastroenterology and Hepatology and.

Teppei Yoshioka (T)

Department of Gastroenterology and Hepatology and.

Minoru Shigekawa (M)

Department of Gastroenterology and Hepatology and.

Ryoko Yamada (R)

Department of Gastroenterology and Hepatology and.

Hayato Hikita (H)

Department of Gastroenterology and Hepatology and.

Ryotaro Sakamori (R)

Department of Gastroenterology and Hepatology and.

Hirofumi Akita (H)

Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Hidetoshi Eguchi (H)

Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Randy L Johnson (RL)

Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Hideki Yokoi (H)

Department of Nephrology, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Masashi Mukoyama (M)

Department of Nephrology, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan.

Tomohide Tatsumi (T)

Department of Gastroenterology and Hepatology and.

Tetsuo Takehara (T)

Department of Gastroenterology and Hepatology and.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH